Myotonic Dystrophy 1 Clinical Trial
Official title:
Effects of a Multiple Component Training Program on Muscles, Maximal Muscle Strength, Endurance and Functional Performance in Adults With Myotonic Dystrophy Type 1: A Pilot Study
Verified date | June 2019 |
Source | Université de Sherbrooke |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A strength and endurance training program was conducted in adults with myotonic dystrophy type 1 (DM1). Participants underwent a 12-week/18-session supervised training program consisted of 6 exercises: elbow flexion/extension, shoulder horizontal adduction, leg press, and knee flexion/extension. To offer a complete training program aimed at improving function it was divided: the first 6 weeks were dedicated to strength-training, whereas the following weeks focused on endurance-training. To evaluate the effects of the training program, participants completed maximal strength, endurance and functional evaluations. Volunteers could also add a muscle biopsy at the beginning and the end of the program to evaluate physiological parameters.
Status | Completed |
Enrollment | 11 |
Est. completion date | December 13, 2013 |
Est. primary completion date | December 13, 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Adults with DM1 - Walk without technical aid - Muscle impairment rating scale (MIRS) of 3 or 4 Exclusion Criteria: - Severe musculoskeletal disorders - Any medical contraindication to physical exercise - Any medical contraindication to muscle biopsies for the biopsy volunteers |
Country | Name | City | State |
---|---|---|---|
Canada | Groupe de recherche interdisciplinaire sur les maladies neuromusculaires | Saguenay | Quebec |
Lead Sponsor | Collaborator |
---|---|
Cynthia Gagnon | Fondation du Grand défi Pierre Lavoie |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in maximal muscle strength in the knee extensors measured by quantified muscle testing | Changes in knee extensor maximal muscle strength evaluated by quantified muscle testing with a handheld dynamometer. | Before and after the 12-week training program | |
Secondary | Change in 6 minute walking test disance | Walking endurance change measured by the 6 minute walking test distance. | Before and after the 12-week training program | |
Secondary | Changes in functional capacity measured by the UQAM-YMCA test | Functional capacity evaluated by 18 functional tests | Before and after the 12-week training program | |
Secondary | Changes in sprint capacity measured by the Running-base anaerobic sprint test | Sprint capacity changes measured by the running-base anaerobic sprint test | Before and after the 12-week training program | |
Secondary | Changes in fatigue measured by the Fatigue severity scale | Fatigue questionnaire: 9-item questionnaire rated on a scale from 1 to 7 for each item. A score a higher score means more fatigue. | Before and after the 12-week training program | |
Secondary | Changes in daytime sleepiness measured by the Daytime sleepiness scale (Epworth Sleepiness Scale) | 8-item questionnaire, rated on a scale from 0 to 3 for each item, the higher the score, the more the patient has daytime sleepiness. | Before and after the 12-week training program | |
Secondary | Changes in stumbles and falls measured by the Falls efficacy scale | 10-item questionnaire about stumbles and falls. All items are rated on a 10-point scale. A higher score means a higher fear of falling. A score over 70 means a significant fear of falling. | Before and after the 12-week training program | |
Secondary | Changes in quality of life measured by the 36-Item Short Form Survey (SF-36) | 36-item quality of life questionnaire. The final score is calculated on a total of 100 where the lower the score, the more disability. A score of 100 means no disability. | Before and after the 12-week training program | |
Secondary | Changes in life habits measured by questionnaire | Life habits questionnaire Assessment of life habits is a 77-item questionnaire with a scale from 0 to 9 for each item. A higher score means no disability and a low score means more disability. | Before and after the 12-week training program | |
Secondary | Changes in muscle biopsy-muscle fiber size | To assess changes in muscle fiber size | Before and after the 12-week training program for volunteers | |
Secondary | Changes in muscle biopsy-muscle fiber typing | To assess changes in muscle fiber typing | Before and after the 12-week training program for volunteers | |
Secondary | Changes in muscle biopsy-proportion of centrally nuclated fibers | To assess changes in muscle centrally nucleated fibers proportion | Before and after the 12-week training program for volunteers | |
Secondary | Changes in muscle biopsy-leucocyte infiltration | To assess changes in muscle fiber leucocyte infiltration | Before and after the 12-week training program for volunteers |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02880735 -
Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
|
N/A | |
Recruiting |
NCT06378216 -
Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]
|
||
Active, not recruiting |
NCT06089018 -
Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
|
||
Completed |
NCT05662150 -
Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1
|
N/A | |
Active, not recruiting |
NCT04698551 -
NIPD on cffDNA for Triplet Repeat Diseases
|
||
Completed |
NCT05027269 -
Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients
|
Phase 1/Phase 2 | |
Completed |
NCT04712422 -
Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
|
||
Recruiting |
NCT05006924 -
Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
|
||
Recruiting |
NCT04656210 -
Myotonic Dystrophy - Vascular and Cognition
|
||
Completed |
NCT04634682 -
Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1
|
N/A | |
Withdrawn |
NCT06270186 -
Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach
|
N/A | |
Recruiting |
NCT06411288 -
Global Study of Del-desiran for the Treatment of DM1
|
Phase 3 | |
Recruiting |
NCT06300307 -
Study of ATX-01 in Participants With DM1
|
Phase 1/Phase 2 | |
Completed |
NCT02729597 -
Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study
|
N/A | |
Recruiting |
NCT06138743 -
Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
|
Phase 1 | |
Not yet recruiting |
NCT05532813 -
Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
|
Phase 3 | |
Active, not recruiting |
NCT04886518 -
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
|
Phase 2 | |
Completed |
NCT05036447 -
Myotonic Dystrophy Type 1 and Resistance Exercise
|
N/A | |
Recruiting |
NCT03424460 -
Venous Thromboembolism in Myotonic Dystrophy Type 1
|
N/A | |
Recruiting |
NCT05865483 -
Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
|